Medical/Pharmaceuticals
First Myeloma Patient Treated with CAR-T Successfully Discharged
SHANGHAI, Jan. 23, 2024 /PRNewswire/ -- In another milestone since the implementation of CAR-T therapy at Jiahui, the first myeloma patient treated with CAR-T at Jiahui International Hospital was recently discharged two weeks after infusion. The foreign patient was first diagnosed with multiple ...
2024-01-23 10:19
2076
Extensive R&D Capabilities：ICP DAS - BMP to Showcase a Broad Range of Medical-Grade TPU at MD&M West 2024, U.S.
HSINCHU, Jan. 23, 2024 /PRNewswire/ -- ICP DAS – BMP, Asia's first medical-grade thermoplastic polyurethane (TPU) supplier, will make its MD&M West debut inthe United States. Kicking off 2024, the company presents a comprehensive range of top-quality medical-grade TPU series to the foremost expe...
2024-01-23 10:06
2575
YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
GAITHERSBURG, Md., Jan. 23, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma") along with its subsidiaries ("YS Group" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and ...
2024-01-23 06:00
2781
Telix Highlights Presentations at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2024)
MELBOURNE, Australia, Jan. 22, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations featuring the Company's theranostic programs at the upcoming American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU 2024) to be he...
2024-01-22 19:00
1595
Everest Medicines Announces 2023 Revenue Expected to be Between RMB124 Million and RMB126 Million
SHANGHAI, Jan. 22, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that the Company expects to record a total reven...
2024-01-22 07:50
3656
Call for Application for 2024 Tsinghua Amgen Scholars Program
BEIJING, Jan. 19, 2024 /PRNewswire/ -- The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of Harvard University, aiming to increase research opportunities for students committed to pursuing careers in the field of biomedical science. Thr...
2024-01-19 15:32
3372
Co-creating a New Future: Infinitus Global Annual Conference 2024 Convenes in Guangdong
GUANGZHOU, China, Jan. 18, 2024 /PRNewswire/ -- Infinitus kicked off 2024 with
the 'Co-creating a New Future' annual conference held in Foshan,Guangdong on
January 13, 2024.
2024-01-19 11:42
2385
PeproMene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) in the Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope
IRVINE, Calif., Jan. 18, 2024 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the cohort 1 first patient treated in its Phase 1 relapsed or refractory B-cell acute lymphoblastic leukemia (...
2024-01-18 16:00
2616
Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Asia Pacific
* Boehringer Ingelheim is recognized as one of 17 Top Employers worldwide and for the fifth consecutive year inAsia Pacific * High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development...
2024-01-18 12:00
1735
Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Thailand
* Boehringer Ingelheim recognized as one of 17 Top Employers worldwide and for the sixth consecutive year inThailand * High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development BANGKO...
2024-01-18 12:00
1559
Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Malaysia
* Boehringer Ingelheim recognized as one of 17 Top Employers worldwide and for the sixth consecutive year inMalaysia * High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development KUALA ...
2024-01-18 12:00
1591
Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Indonesia
* Boehringer Ingelheim recognized as one of 17 Top Employers worldwide and for the sixth consecutive year inIndonesia * High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development JAK...
2024-01-18 12:00
1546
Asian Smart Medical Online Exhibition 2024 Grand Opening
TAIPEI, Jan. 18, 2024 /PRNewswire/ -- Asian Smart Medical Online Exhibition (Medical Asia 2024) is a virtual and physical integration targeting Asian suppliers, importers, and exporters. It will be exhibited fromJanuary 17, 2024, toJune 30, 2024, and will be an excellent opportunity for exhibitor...
2024-01-18 11:08
2007
Seno Medical Earns Frost & Sullivan's 2023 United States Enabling Technology Leadership Award for Delivering a More Efficient Breast Cancer Diagnosis with Its Cutting-edge Technology
Seno Medical offers highly differentiated opto-acoustic/ultrasound (OA/US) exam to diagnose breast cancer and significantly reduce unnecessary breast biopsies. SAN ANTONIO, Jan. 17, 2024 /PRNewswire/ -- Frost & Sullivan recently recognizedSeno Medical with the 2023 US Enabling Technology Leadersh...
2024-01-17 23:00
1616
Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
- Data from first tranche of MSS CRC patients treated with ADG126 10 mg/kg every three weeks (Q3W) in dose expansionshowed clinical benefit including confirmed responses at higher, more frequent and repeat doses of the anti-CTLA-4 therapy - - Preliminary survival analysis of ADG126 10 mg/kg do...
2024-01-17 20:00
2871
SeptiCyte RAPID® By Immunexpress Receives Regulatory Clearance from Australian Therapeutic Goods Administration (TGA)
The Cost of Sepsis in Australia report (2021) estimated that there are >90,000 sepsis cases inAustralia each year and estimated direct and indirect costs of $700 million and $4 billion respectively SEATTLE and BRISBANE, Australia, Jan. 17, 2024 /PRNewswire/ -- Immunexpress, Pty Ltd., a molecular...
2024-01-17 06:00
1872
FIRST PATIENTS ENROLLED IN THE GORE VBX FORWARD CLINICAL STUDY
This study aims to compare the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease with the goal of informing practice guidelines around which modality is best suited for patients with this...
2024-01-16 21:00
1510
Epitomee® Announces Successful Completion of Pivotal Clinical Trial for Innovative Weight Loss Capsule
CAESAREA, Israel, Jan. 16, 2024 /PRNewswire/ -- Epitomee® announces the successful completion of the RESET pivotal clinical trial, for its weight loss capsule. The randomized placebo controlled, double blind trial, investigated the safety and efficacy of Epitomee® capsule versus the sham capsule ...
2024-01-16 21:00
1849
HOPE FOR FEMALE CANCER PATIENTS TO PRESERVE FERTILITY THROUGH OVARIAN TISSUE CRYOPRESERVATION AT SUNFERT
Sunfert International Fertility Centre is the First Private Oncofertility Hub in Malaysia KUALA LUMPUR, Malaysia, Jan. 16, 2024 /PRNewswire/ -- Reproductive medicine has achieved groundbreaking milestones, andMalaysia is one of the countries that is sought after by couples near and far to realis...
2024-01-16 18:14
1691
TVM Capital Healthcare invests in Vietnamese Eye Care Business Alina Vision in a Growth-Buy Out Transaction
Alina Vision operates hospitals in the underserved Vietnamese ophthalmology market, providing affordable and high-quality eye care services for people across all income levels to combat avoidable blindness; and meeting the impact investing strategy of TVM Capital Healthcare SINGAPORE and HANOI, ...
2024-01-16 16:55
2071
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
6494
